Oral News and Research

RSS

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more.

5 Jun 2023

Fluoridated water: Essential ingredient in U.S. water systems for cavity prevention and dental health equity

Fluoridated water at recommended levels reduces dental cavities by 25%, emphasizing the importance of maintaining fluoride levels for effective caries prevention. Most water systems comply with safety standards, providing the full benefits of fluoridation.

4 Jun 2023

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients.

2 Jun 2023

Real-world management and outcomes of U.S. patients treated with BpaL for rifampin-resistant tuberculosis

Researchers reported on the treatment of rifampin-resistant tuberculosis in the United States using the FDA approved bedaquiline, pretomanid, and linezolid (BPaL) therapy.

1 Jun 2023

Breast cancer patients experience more severe CIPN symptoms with paclitaxel

Chemotherapy-induced peripheral neuropathy (CIPN) – nerve pain, tingling, or numbness in the hands or feet – is a common side effect of certain cancer treatments, including two drugs frequently used to treat cancer – the taxanes paclitaxel and docetaxel.

31 May 2023

Cardiovascular comobidities in RA patients

The increased cardiovascular risks in RA include acute coronary syndromes (ACS). The extent to which DMARD-induced remission could reduce the risk of ACS in RA versus rates in the general population – and whether there are DMARD-specific beneficial effects on ACS risk – remain unknown.

31 May 2023

Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

An extended lymphadenectomy – removal of additional lymph nodes beyond the extent of the standard procedure – in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because of clinically localized muscle-invasive bladder cancer provides no patient benefit as measured by disease-free survival or overall survival times.

30 May 2023

Treatment with modified lactic acid bacteria accelerates the healing of wounds, study shows

Complicated, hard-to-heal wounds are a growing medical problem and there are currently only two drugs approved with proven efficacy.

30 May 2023

One-day keto diet boosts energy expenditure, exogenous ketones have little effect

Research aims to compare the effects of a one-day isocaloric ketogenic diet, fasting, and supplementation with ketone salts on energy expenditure and appetite perception. The study found that a 24-hour ketogenic diet may contribute to maintaining a neutral energy balance by increasing energy expenditure.

29 May 2023

Researchers develop microrobotic system capable of rapid, targeted elimination of fungal pathogens

Infections caused by fungi, such as Candida albicans, pose a significant global health risk due to their resistance to existing treatments, so much so that the World Health Organization has highlighted this as a priority issue.

26 May 2023

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Several phase 3 studies conducted by researchers from Dana-Farber Cancer Institute show promising results for patients with rectal, brain, and kidney cancers. The results of these studies, along with dozens of others led by Dana-Farber researchers, will be presented at the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.

26 May 2023

Telephone-based weight loss program can help patients with breast cancer to reduce their weight

Women with obesity when they are diagnosed with early breast cancer have a higher risk of recurrence or a second cancer compared to women whose weight is in the normal range and it can be hard to lose weight after being diagnosed with breast cancer.

26 May 2023

Recent evolution of the LAAO therapy for thromboembolic complications

Announcing a new article publication for Cardiovascular Innovations and Applications journal.

26 May 2023

New method of analysis flags a precursor to prediabetes

Scientists at Klick Labs have developed a new way to catch the earliest signs the human body is failing to control blood glucose levels, before it reaches prediabetic levels in patients.

25 May 2023

Women with menstrual cycle dysfunction may experience adverse cardiovascular health consequences

A study of more than 58,000 women over a 12-year period found that longer or shorter menstrual cycles were associated with a higher risk of developing cardiovascular disease, heart attack or atrial fibrillation (AFib), according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

24 May 2023

The adaptive immunity of human endemic viruses

Researchers studied the evolution of the ability of viruses to evade the neutralizing antibodies.

24 May 2023

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Researchers assessed the safety and efficacy of danuglipron in type 2 diabetes (T2D) patients.

24 May 2023

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

Research investigates the effectiveness of oral antiviral medications, Molnupiravir and Nirmatrelvir-Ritonavir, in treating patients with type 2 diabetes and mild to moderate COVID-19. The study aims to determine the efficacy of these medications in reducing adverse outcomes in this specific population.

24 May 2023

The antimicrobial potential of nanoparticles

Nanoparticles have widely been used as advanced tools for the diagnosis, prevention, and treatment of infectious diseases.

23 May 2023

Gut check: Our microbiome's vitamin factory could redefine personal health

Research highlights the crucial role of vitamins in metabolic and regulatory processes. It explores the microbial contribution of essential vitamins, such as vitamin K and B-group vitamins, in the gastrointestinal tract, emphasizing their impact on human health and the gut microbiome.

23 May 2023

Oral News and Research

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Fluoridated water: Essential ingredient in U.S. water systems for cavity prevention and dental health equity

University of Louisville researchers receive $5.8 million to prevent immune system dysregulation

Real-world management and outcomes of U.S. patients treated with BpaL for rifampin-resistant tuberculosis

Breast cancer patients experience more severe CIPN symptoms with paclitaxel

Cardiovascular comobidities in RA patients

Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

Treatment with modified lactic acid bacteria accelerates the healing of wounds, study shows

One-day keto diet boosts energy expenditure, exogenous ketones have little effect

Researchers develop microrobotic system capable of rapid, targeted elimination of fungal pathogens

Phase 3 studies for rectal, brain, and kidney cancers to be presented by Dana-Farber researchers at ASCO 2023

Telephone-based weight loss program can help patients with breast cancer to reduce their weight

Recent evolution of the LAAO therapy for thromboembolic complications

New method of analysis flags a precursor to prediabetes

Women with menstrual cycle dysfunction may experience adverse cardiovascular health consequences

The adaptive immunity of human endemic viruses

What is the efficacy, safety, and tolerability of novel danuglipron in adults with type two diabetes?

Oral antivirals Molnupiravir and Nirmatrelvir-Ritonavir lower COVID-19 risks in type 2 diabetes patients

The antimicrobial potential of nanoparticles

Gut check: Our microbiome's vitamin factory could redefine personal health

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News